Secondary prevention of cervical cancer part 1: screening for cervical cancer and its precursors

Michelle Boisen; Justin T Diedrich; Neal M Lonky; Richard Guido

doi:10.1097/GRF.0000000000000032

Secondary prevention of cervical cancer part 1: screening for cervical cancer and its precursors

Clin Obstet Gynecol. 2014 Jun;57(2):279-91. doi: 10.1097/GRF.0000000000000032.

Authors

Michelle Boisen¹, Justin T Diedrich, Neal M Lonky, Richard Guido

Affiliation

¹ *Magee-Womens Hospital of the UPMC System, University of Pittsburgh, Pittsburgh, Pennsylvania †Washington University in St. Louis, St Louis, Missouri ‡Southern California Permanente Medical Group, Department of Obstetrics and Gynecology, Kaiser Permanente, Anhaheim, and Department of Obstetrics and Gynecology, University of California School of Medicine, Irvine, California.

PMID: 24785416
DOI: 10.1097/GRF.0000000000000032

Abstract

Discussion of screening for cervical cancer and it precursors, management of abnormal cervical cancer screening test, and evidence-based management of women with cervical intraepithelial neoplasia.

MeSH terms

Automation
Female
Humans
Immunoassay / methods
Mass Screening / methods*
Mass Screening / standards*
Polymerase Chain Reaction
Practice Guidelines as Topic
Secondary Prevention*
Uterine Cervical Dysplasia / diagnosis
Uterine Cervical Dysplasia / prevention & control*
Uterine Cervical Neoplasms / diagnosis
Uterine Cervical Neoplasms / prevention & control*
Vaginal Smears